Psychiatry Research: Neuroimaging
Volume 172, Issue 1 , Pages 31-37 , 30 April 2009

5-HT1A receptor and 5-HTT binding during the menstrual cycle in healthy women examined with [11C] WAY100635 and [11C] MADAM PET

  • Hristina Jovanovic

      Affiliations

    • Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Stockholm, Sweden
    • ,
  • Per Karlsson

      Affiliations

    • Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Stockholm, Sweden
    • ,
  • Åsta Cerin

      Affiliations

    • bKarolinska Institutet, Department of Woman and Child Health and Stockholm Brain Institute, Stockholm, Sweden
    • ,
  • Christer Halldin

      Affiliations

    • Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Stockholm, Sweden
    • ,
  • Anna-Lena Nordström

      Affiliations

    • Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, Stockholm, Sweden
    • Corresponding Author InformationCorresponding author. Karolinska Institute, Department of Clinical Neuroscience, Psychiatry Section, 171 76 Stockholm, Sweden. Tel.: +46 8 517 744 65; fax: +46 8 517 717 53.

Received 31 August 2007 ,Revised 1 June 2008 ,Accepted 4 July 2008.

References 

  1. Ballinger S. Stress as a factor in lowered estrogen levels in the early postmenopause. Annals of the New York Academy of Sciences. 1990;592:95–113discussion 123–133
  2. Bergstrom M, Boethius J, Eriksson L, Greitz T, Ribbe T, Widen L. Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. Journal of Computer Assisted Tomography. 1981;5:136–141
  3. Best SE, Sarrel PM, Malison RT, Laruelle M, Zoghbi SS, Baldwin RM, et al. Striatal dopamine transporter availability with [123I]beta-CIT SPECT is unrelated to gender or menstrual cycle. Psychopharmacology (Berl). 2005;183:181–189
  4. Cortes R, Soriano E, Pazos A, Probst A, Palacios JM. Autoradiography of antidepressant binding sites in the human brain: localization using [3H]imipramine and [3H]paroxetine. Neuroscience. 1988;27:473–496
  5. Crespo-Facorro B, Kim J, Andreasen NC, Spinks R, O'Leary DS, Bockholt HJ, et al. Cerebral cortex: a topographic segmentation method using magnetic resonance imaging. Psychiatry Research. 2000;100:97–126
  6. Farde L, Ito H, Swahn CG, Pike VW, Halldin C. Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man. Journal of Nuclear Medicine. 1998;39:1965–1971
  7. Filicori M, Butler JP, Crowley WF. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. Jourbal of Clinical Investigation. 1984;73:1638–1647
  8. Filicori M, Santoro N, Merriam GR, Crowley WF. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. Journal of Clinical Endocrinology and Metabolism. 1986;62:1136–1144
  9. FitzGerald M, Malone KM, Li S, Harrison WM, McBride PA, Endicott J, et al. Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder. American Journal of Psychiatry. 1997;154:556–558
  10. Fludder JM, Tonge SR. Proceedings: variations in the concentrations of monamines and their metabolites in eight regions of rat brain during the oestrous cycle: a basis for interactions between hormones and psychotropic drugs. Journal of Pharmacy and Pharmacology. 1975;27(Suppl?-2):39
  11. Flugge G, Pfender D, Rudolph S, Jarry H, Fuchs E. 5HT1A-receptor binding in the brain of cyclic and ovariectomized female rats. Journal of Neuroendocrinology. 1999;11:243–249
  12. Gorman JM. Gender differences in depression and response to psychotropic medication. Gender Medicine. 2006;3:93–109
  13. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996;347:930–933
  14. Gunn RN, Sargent PA, Bench CJ, Rabiner EA, Osman S, Pike VW, et al. Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET. Neuroimage. 1998;8:426–440
  15. Hall H, Lundkvist C, Halldin C, Farde L, Pike VW, McCarron JA, et al. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Research. 1997;745:96–108
  16. Halldin C, Lundberg J, Sovago J, Gulyas B, Guilloteau D, Vercouillie J, et al. [(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET. Synapse. 2005;58:173–183
  17. Jovanovic H, Cerin A, Karlsson P, Lundberg J, Halldin C, Nordstrom AL. A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria. Psychiatry Research. 2006;148:185–193
  18. Krasikova RN, Truong P, Halldin C. A fully automated production of [carbolyl-11C]WAY-10035 for clinical PET studies. Journal of Labelled Compounds and Radiopharmaceuticals. 2003;46:244
  19. Kueng W, Wirz-Justice A, Menzi R, Chappuis-Arndt E. Regional brain variations of tryptophan, monoamines, monoamine oxidase activity, plasma free and total tryptophan during the estrous cycle of the rat. Neuroendocrinology. 1976;21:289–296
  20. Lundberg J, Odano I, Olsson H, Halldin C, Farde L. Quantification of 11C-MADAM binding to the serotonin transporter in the human brain. Journal of Nuclear Medicine. 2005;46:1505–1515
  21. Lundberg J, Halldin C, Farde L. Measurement of serotonin transporter binding with PET and [11C]MADAM: a test–retest reproducibility study. Synapse. 2006;60:256–263
  22. Maswood S, Truitt W, Hotema M, Caldarola-Pastuszka M, Uphouse L. Estrous cycle modulation of extracellular serotonin in mediobasal hypothalamus: role of the serotonin transporter and terminal autoreceptors. Brain Research. 1999;831:146–154
  23. McQueen JK, Wilson H, Fink G. Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. Brain Research Molecular Brain Research. 1997;45:13–23
  24. Moses EL, Drevets WC, Smith G, Mathis CA, Kalro BN, Butters MA, et al. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biological Psychiatry. 2000;48:854–860
  25. Nordstrom AL, Olsson H, Halldin C. A PET study of D2 dopamine receptor density at different phases of the menstrual cycle. Psychiatry Research. 1998;83:1–6
  26. Parsey RV, Arango V, Olvet DM, Oquendo MA, Van Heertum RL, John Mann J. Regional heterogeneity of 5-HT1A receptors in human cerebellum as assessed by positron emission tomography. Journal of Cerebral Blood Flow and Metabolism. 2005;25:785–793
  27. Pearlstein T, Rosen K, Stone AB. Mood disorders and menopause. Endocrinology and Metabolism Clinics of North America. 1997;26:279–294
  28. Pecins-Thompson M, Bethea CL. Ovarian steroid regulation of serotonin-1A autoreceptor messenger RNA expression in the dorsal raphe of rhesus macaques. Neuroscience. 1999;89:267–277
  29. Pecins-Thompson M, Brown NA, Bethea CL. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Research Molecular Brain Research. 1998;53:120–129
  30. Pigott TA. Gender differences in the epidemiology and treatment of anxiety disorders. Journal of Clinical Psychiatry. 1999;60(Suppl 18):4–15
  31. Plenge P, Mellerup ET, Laursen H. Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine. Progress in Neuro-psychopharmacology Biological Psychiatry. 1990;14:61–72
  32. Rossmanith WG, Laughlin GA, Mortola JF, Johnson ML, Veldhuis JD, Yen SS. Pulsatile cosecretion of estradiol and progesterone by the midluteal phase corpus luteum: temporal link to luteinizing hormone pulses. Journal of Clinical Endocrinology and Metabolism. 1990;70:990–995
  33. Rubinow DR, Schmidt PJ, Roca CA. Estrogen–serotonin interactions: implications for affective regulation. Biological Psychiatry. 1998;44:839–850
  34. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. American Journal of Obstetrics and Gynecology. 2000;183:414–420
  35. Slater P, Doyle CA, Deakin JF. Abnormal persistence of cerebellar serotonin-1A receptors in schizophrenia suggests failure to regress in neonates. Journal of Neural Transmission. 1998;105:305–315
  36. Steiner M, Dunn E, Born L. Hormones and mood: from menarche to menopause and beyond. Journal of Affective Disorders. 2003;74:67–83
  37. Su TP, Schmidt PJ, Danaceau M, Murphy DL, Rubinow DR. Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. Journal of Clinical Endocrinology and Metabolism. 1997;82:1220–1228
  38. Wienhard K, Dahlbom M, Eriksson L, Michel C, Bruckbauer T, Pietrzyk U, et al. The ECAT EXACT HR: performance of a new high resolution positron scanner. Journal of Computer Assisted Tomography. 1994;18:110–118
  39. Young EA, Midgley AR, Carlson NE, Brown MB. Alteration in the hypothalamic–pituitary–ovarian axis in depressed women. Archives of General Psychiatry. 2000;57:1157–1162

☆ This study was supported by grants from the Swedish Research Council 21222063 VR21X-14567-03A, 21222073 VR21B1-15319-01A.

PII: S0925-4927(08)00095-4

doi: 10.1016/j.pscychresns.2008.07.002

Psychiatry Research: Neuroimaging
Volume 172, Issue 1 , Pages 31-37 , 30 April 2009

Article Tools

* Image Usage & Resolution